JP2009537595A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537595A5 JP2009537595A5 JP2009511485A JP2009511485A JP2009537595A5 JP 2009537595 A5 JP2009537595 A5 JP 2009537595A5 JP 2009511485 A JP2009511485 A JP 2009511485A JP 2009511485 A JP2009511485 A JP 2009511485A JP 2009537595 A5 JP2009537595 A5 JP 2009537595A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- group
- piperidin
- methoxy
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 45
- 125000001188 haloalkyl group Chemical group 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 28
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 27
- -1 monoalkylamino Chemical group 0.000 claims 26
- 239000002253 acid Substances 0.000 claims 23
- 125000003545 alkoxy group Chemical group 0.000 claims 23
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000004663 dialkyl amino group Chemical group 0.000 claims 17
- 125000004438 haloalkoxy group Chemical group 0.000 claims 16
- 125000002252 acyl group Chemical group 0.000 claims 15
- 125000003118 aryl group Chemical group 0.000 claims 15
- 125000001424 substituent group Chemical group 0.000 claims 15
- 125000004414 alkyl thio group Chemical group 0.000 claims 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- 150000002148 esters Chemical class 0.000 claims 13
- 125000004995 haloalkylthio group Chemical group 0.000 claims 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 13
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 13
- 150000001408 amides Chemical class 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000004432 carbon atom Chemical group C* 0.000 claims 7
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 7
- 201000010153 skin papilloma Diseases 0.000 claims 7
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 208000000260 Warts Diseases 0.000 claims 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000000651 prodrug Chemical group 0.000 claims 4
- 229940002612 prodrug Drugs 0.000 claims 4
- 241001631646 Papillomaviridae Species 0.000 claims 3
- 125000004185 ester group Chemical group 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004434 sulfur atom Chemical group 0.000 claims 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000007062 hydrolysis Effects 0.000 claims 2
- 238000006460 hydrolysis reaction Methods 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 125000005541 phosphonamide group Chemical group 0.000 claims 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims 2
- 229940124530 sulfonamide Drugs 0.000 claims 2
- 150000003456 sulfonamides Chemical class 0.000 claims 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 2
- 150000003536 tetrazoles Chemical class 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- LVSQBGJIBYJFBC-UHFFFAOYSA-N 1-(2-methyl-6-piperidin-1-ylphenyl)-1-[4-(trifluoromethoxy)phenyl]hydrazine Chemical compound C=1C=C(OC(F)(F)F)C=CC=1N(N)C=1C(C)=CC=CC=1N1CCCCC1 LVSQBGJIBYJFBC-UHFFFAOYSA-N 0.000 claims 1
- SHDANUMTEWFBAB-UHFFFAOYSA-N 1-(3-phenoxyphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=1)=CC=CC=1OC1=CC=CC=C1 SHDANUMTEWFBAB-UHFFFAOYSA-N 0.000 claims 1
- GWPXAKGQGKGEHP-UHFFFAOYSA-N 1-(4-benzylphenyl)-1-(2-methyl-6-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=C(CC=2C=CC=CC=2)C=CC=1N(N)C=1C(C)=CC=CC=1N1CCCCC1 GWPXAKGQGKGEHP-UHFFFAOYSA-N 0.000 claims 1
- MLIIKBWHZWPLEF-UHFFFAOYSA-N 1-(4-benzylphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1CC1=CC=CC=C1 MLIIKBWHZWPLEF-UHFFFAOYSA-N 0.000 claims 1
- YOMXWXKPUPXJBY-UHFFFAOYSA-N 1-(4-bromophenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C1=CC=C(Br)C=C1 YOMXWXKPUPXJBY-UHFFFAOYSA-N 0.000 claims 1
- JEDKEMQGKRGHPJ-UHFFFAOYSA-N 1-(4-cyclohexylphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1C1CCCCC1 JEDKEMQGKRGHPJ-UHFFFAOYSA-N 0.000 claims 1
- UYKIMJVFSRBMFM-UHFFFAOYSA-N 1-(4-methoxyphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C1=CC(OC)=CC=C1N(N)C1=CC=CC=C1N1CCCCC1 UYKIMJVFSRBMFM-UHFFFAOYSA-N 0.000 claims 1
- PMBRUDGDSOPIEK-UHFFFAOYSA-N 1-(4-phenoxyphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1OC1=CC=CC=C1 PMBRUDGDSOPIEK-UHFFFAOYSA-N 0.000 claims 1
- FEIZXUUGZOGGFR-UHFFFAOYSA-N 1-(4-phenylmethoxyphenyl)-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1OCC1=CC=CC=C1 FEIZXUUGZOGGFR-UHFFFAOYSA-N 0.000 claims 1
- QZDASZPENQHNDU-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound COC1=CC=CC(CN(N)C=2C(=CC=CC=2)N2CCCCC2)=C1 QZDASZPENQHNDU-UHFFFAOYSA-N 0.000 claims 1
- NQBOOFUWYNHREX-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C1=CC(OC)=CC=C1CN(N)C1=CC=CC=C1N1CCCCC1 NQBOOFUWYNHREX-UHFFFAOYSA-N 0.000 claims 1
- ANYQCYYCRWNJPR-UHFFFAOYSA-N 1-[2-(4-methoxyphenyl)ethyl]-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C1=CC(OC)=CC=C1CCN(N)C1=CC=CC=C1N1CCCCC1 ANYQCYYCRWNJPR-UHFFFAOYSA-N 0.000 claims 1
- DCEPMVQCVPQNRZ-UHFFFAOYSA-N 1-[4-(4-fluorophenoxy)phenyl]-1-(2-methyl-6-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=C(OC=2C=CC(F)=CC=2)C=CC=1N(N)C=1C(C)=CC=CC=1N1CCCCC1 DCEPMVQCVPQNRZ-UHFFFAOYSA-N 0.000 claims 1
- ULYFJTBXDKSXHF-UHFFFAOYSA-N 1-[4-(4-fluorophenoxy)phenyl]-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 ULYFJTBXDKSXHF-UHFFFAOYSA-N 0.000 claims 1
- IBEJMYIPZYIAHO-UHFFFAOYSA-N 1-[4-(4-methoxyphenyl)phenyl]-1-(2-methyl-6-piperidin-1-ylphenyl)hydrazine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(N(N)C=2C(=CC=CC=2C)N2CCCCC2)C=C1 IBEJMYIPZYIAHO-UHFFFAOYSA-N 0.000 claims 1
- OGLULPSAYFPEIQ-UHFFFAOYSA-N 1-[4-(4-methoxyphenyl)phenyl]-1-(2-piperidin-1-ylphenyl)hydrazine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(N(N)C=2C(=CC=CC=2)N2CCCCC2)C=C1 OGLULPSAYFPEIQ-UHFFFAOYSA-N 0.000 claims 1
- RKRHISHCYGTUMP-UHFFFAOYSA-N 1-[4-[4-(2-methyl-1,3-dithian-2-yl)phenyl]phenyl]-1-(2-methyl-6-piperidin-1-ylphenyl)hydrazine Chemical compound C=1C=C(C=2C=CC(=CC=2)C2(C)SCCCS2)C=CC=1N(N)C=1C(C)=CC=CC=1N1CCCCC1 RKRHISHCYGTUMP-UHFFFAOYSA-N 0.000 claims 1
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 claims 1
- MJPPGVVIDGQOQT-UHFFFAOYSA-N 2-bromo-5-(2-bromo-2-nitroethenyl)furan Chemical compound [O-][N+](=O)C(Br)=CC1=CC=C(Br)O1 MJPPGVVIDGQOQT-UHFFFAOYSA-N 0.000 claims 1
- CQLYYYCUJAPEOK-UHFFFAOYSA-N 4-[2-[2-(4-benzoylphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid hydrochloride Chemical compound Cl.C(C1=CC=CC=C1)(=O)C1=CC=C(C=C1)N(NC(=O)CC1=CC(=C(C(=O)O)C=C1Br)OC)C1=C(C=CC=C1)N1CCCCC1 CQLYYYCUJAPEOK-UHFFFAOYSA-N 0.000 claims 1
- PYDPVYMURKJIIO-UHFFFAOYSA-N 4-[2-[2-(4-benzylphenyl)-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(CC=3C=CC=CC=3)=CC=2)C=2C(=CC=CC=2C)N2CCCCC2)=C1Br PYDPVYMURKJIIO-UHFFFAOYSA-N 0.000 claims 1
- GIHPVEIBSGCDFI-UHFFFAOYSA-N 4-[2-[2-(4-benzylphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(CC=3C=CC=CC=3)=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br GIHPVEIBSGCDFI-UHFFFAOYSA-N 0.000 claims 1
- MQXWIFOUTDAODG-UHFFFAOYSA-N 4-[2-[2-[4-(3-acetylphenyl)phenyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-chloro-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)C=2C=C(C=CC=2)C(C)=O)C=2C(=CC=CC=2)N2CCCCC2)=C1Cl MQXWIFOUTDAODG-UHFFFAOYSA-N 0.000 claims 1
- JHVHAYVFPLNMSK-UHFFFAOYSA-N 4-[2-[2-[4-(4-acetylphenyl)phenyl]-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)C=2C=CC(=CC=2)C(C)=O)C=2C(=CC=CC=2C)N2CCCCC2)=C1Br JHVHAYVFPLNMSK-UHFFFAOYSA-N 0.000 claims 1
- HDZUJKKVJOIICW-UHFFFAOYSA-N 4-[2-[2-[4-(4-acetylphenyl)phenyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-chloro-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)C=2C=CC(=CC=2)C(C)=O)C=2C(=CC=CC=2)N2CCCCC2)=C1Cl HDZUJKKVJOIICW-UHFFFAOYSA-N 0.000 claims 1
- RFEFPJQPAJFDMS-UHFFFAOYSA-N 4-[2-[2-[4-(4-fluorophenoxy)phenyl]-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OC=3C=CC(F)=CC=3)=CC=2)C=2C(=CC=CC=2C)N2CCCCC2)=C1 RFEFPJQPAJFDMS-UHFFFAOYSA-N 0.000 claims 1
- QJEWWPSYKNRFEA-UHFFFAOYSA-N 4-[2-[2-[4-(benzenesulfinyl)phenyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)S(=O)C=2C=CC=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br QJEWWPSYKNRFEA-UHFFFAOYSA-N 0.000 claims 1
- JMKFYSZNKLBRLU-UHFFFAOYSA-N 4-[2-[2-[4-(benzenesulfonyl)phenyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-5-bromo-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)S(=O)(=O)C=2C=CC=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br JMKFYSZNKLBRLU-UHFFFAOYSA-N 0.000 claims 1
- VWXFUUPZQQUKEL-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-[2-(4-methoxyphenyl)-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1N(C=1C(=CC=CC=1C)N1CCCCC1)NC(=O)CC1=CC(OC)=C(C(O)=O)C=C1Br VWXFUUPZQQUKEL-UHFFFAOYSA-N 0.000 claims 1
- MZSPKVOLOHHPGH-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-[2-(4-methoxyphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1N(C=1C(=CC=CC=1)N1CCCCC1)NC(=O)CC1=CC(OC)=C(C(O)=O)C=C1Br MZSPKVOLOHHPGH-UHFFFAOYSA-N 0.000 claims 1
- MTYNNXGHHIATQD-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-[2-[(3-methoxyphenyl)methyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]benzoic acid;hydrochloride Chemical compound Cl.COC1=CC=CC(CN(NC(=O)CC=2C(=CC(=C(OC)C=2)C(O)=O)Br)C=2C(=CC=CC=2)N2CCCCC2)=C1 MTYNNXGHHIATQD-UHFFFAOYSA-N 0.000 claims 1
- NZRZZTZSNFCQGR-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-[2-[(4-methoxyphenyl)methyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CN(C=1C(=CC=CC=1)N1CCCCC1)NC(=O)CC1=CC(OC)=C(C(O)=O)C=C1Br NZRZZTZSNFCQGR-UHFFFAOYSA-N 0.000 claims 1
- AGUVLTRJAJOBEJ-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-[2-[4-(4-methoxyphenyl)phenyl]-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1C1=CC=C(N(NC(=O)CC=2C(=CC(=C(OC)C=2)C(O)=O)Br)C=2C(=CC=CC=2C)N2CCCCC2)C=C1 AGUVLTRJAJOBEJ-UHFFFAOYSA-N 0.000 claims 1
- CVHLEOGXAWVGSK-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-oxo-2-[2-(2-piperidin-1-ylphenyl)-2-[4-(trifluoromethoxy)phenyl]hydrazinyl]ethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OC(F)(F)F)=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br CVHLEOGXAWVGSK-UHFFFAOYSA-N 0.000 claims 1
- ARLNBJKPBVJQOS-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-oxo-2-[2-(3-phenoxyphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]ethyl]benzoic acid hydrochloride Chemical compound Cl.BrC=1C(=CC(=C(C(=O)O)C1)OC)CC(=O)NN(C1=C(C=CC=C1)N1CCCCC1)C1=CC(=CC=C1)OC1=CC=CC=C1 ARLNBJKPBVJQOS-UHFFFAOYSA-N 0.000 claims 1
- ZHKKUNRVYFVHGR-UHFFFAOYSA-N 5-bromo-2-methoxy-4-[2-oxo-2-[2-(4-phenylmethoxyphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]ethyl]benzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br ZHKKUNRVYFVHGR-UHFFFAOYSA-N 0.000 claims 1
- IVECYPUUSBRFMU-UHFFFAOYSA-N 5-bromo-4-[2-[2-(4-cyclohexyloxyphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OC3CCCCC3)=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br IVECYPUUSBRFMU-UHFFFAOYSA-N 0.000 claims 1
- FJMGLBGCKIPHPX-UHFFFAOYSA-N 5-bromo-4-[2-[2-(4-cyclohexylphenyl)-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(=CC=2)C2CCCCC2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br FJMGLBGCKIPHPX-UHFFFAOYSA-N 0.000 claims 1
- OPUSXQOPSNEHII-UHFFFAOYSA-N 5-bromo-4-[2-[2-[4-(4-chlorophenoxy)phenyl]-2-(2-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OC=3C=CC(Cl)=CC=3)=CC=2)C=2C(=CC=CC=2)N2CCCCC2)=C1Br OPUSXQOPSNEHII-UHFFFAOYSA-N 0.000 claims 1
- VWHPEFOSNIZPEE-UHFFFAOYSA-N 5-bromo-4-[2-[2-[4-(4-fluorophenoxy)phenyl]-2-(2-methyl-6-piperidin-1-ylphenyl)hydrazinyl]-2-oxoethyl]-2-methoxybenzoic acid;hydrochloride Chemical compound Cl.C1=C(C(O)=O)C(OC)=CC(CC(=O)NN(C=2C=CC(OC=3C=CC(F)=CC=3)=CC=2)C=2C(=CC=CC=2C)N2CCCCC2)=C1Br VWHPEFOSNIZPEE-UHFFFAOYSA-N 0.000 claims 1
- 206010059313 Anogenital warts Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 208000000907 Condylomata Acuminata Diseases 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- 206010068322 Oral papilloma Diseases 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- UZEZODGYGGMGSV-UHFFFAOYSA-N [4-(n-amino-2-piperidin-1-ylanilino)phenyl]-phenylmethanone Chemical compound C=1C=CC=C(N2CCCCC2)C=1N(N)C(C=C1)=CC=C1C(=O)C1=CC=CC=C1 UZEZODGYGGMGSV-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 claims 1
- 201000004201 anogenital venereal wart Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- LCIYFINKFGDAHD-UHFFFAOYSA-N azepane;3-nitrobenzoic acid Chemical compound C1CCCNCC1.OC(=O)C1=CC=CC([N+]([O-])=O)=C1 LCIYFINKFGDAHD-UHFFFAOYSA-N 0.000 claims 1
- JXHYCCGOZUGBFD-UHFFFAOYSA-N benzoic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1 JXHYCCGOZUGBFD-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 210000003464 cuspid Anatomy 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 230000009547 development abnormality Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000009841 epithelial lesion Effects 0.000 claims 1
- 150000002429 hydrazines Chemical class 0.000 claims 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 1
- 239000000543 intermediate Substances 0.000 claims 1
- 208000020082 intraepithelial neoplasia Diseases 0.000 claims 1
- 210000000867 larynx Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000003154 papilloma Diseases 0.000 claims 1
- 208000029211 papillomatosis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0604496 | 2006-05-19 | ||
| FR0604496A FR2901273B1 (fr) | 2006-05-19 | 2006-05-19 | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| PCT/EP2007/054843 WO2007135106A1 (fr) | 2006-05-19 | 2007-05-18 | Derives de piperidine comme inhibiteurs du virus du papillome humain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009537595A JP2009537595A (ja) | 2009-10-29 |
| JP2009537595A5 true JP2009537595A5 (enExample) | 2012-06-07 |
| JP5399237B2 JP5399237B2 (ja) | 2014-01-29 |
Family
ID=37575135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511485A Expired - Fee Related JP5399237B2 (ja) | 2006-05-19 | 2007-05-18 | ヒトパピローマウイルス阻害剤としてのピペリジン誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8207373B2 (enExample) |
| EP (1) | EP2024350B1 (enExample) |
| JP (1) | JP5399237B2 (enExample) |
| CN (1) | CN101466693B (enExample) |
| AR (1) | AR061027A1 (enExample) |
| BR (1) | BRPI0711208A2 (enExample) |
| CA (1) | CA2652469C (enExample) |
| DK (1) | DK2024350T3 (enExample) |
| ES (1) | ES2436772T3 (enExample) |
| FR (1) | FR2901273B1 (enExample) |
| MX (1) | MX2008014771A (enExample) |
| PT (1) | PT2024350E (enExample) |
| WO (1) | WO2007135106A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2923825B1 (fr) * | 2007-11-20 | 2013-05-03 | Anaconda Pharma | Nouveaux inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant. |
| FR2990134B1 (fr) * | 2012-05-07 | 2014-11-21 | Anaconda Pharma | Composition pharmaceutique d'un inhibiteur du virus du papillome |
| FR3000490B1 (fr) * | 2012-12-27 | 2015-03-13 | Anaconda Pharma | Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome |
| ES2796276T3 (es) * | 2015-02-05 | 2020-11-26 | Ab Science | Compuestos con actividad antitumoral |
| WO2017009751A1 (en) | 2015-07-15 | 2017-01-19 | Pfizer Inc. | Pyrimidine derivatives |
| CN105582083A (zh) * | 2015-09-08 | 2016-05-18 | 石友爱 | 一种治疗鲍温样丘疹病的中药 |
| WO2018157843A1 (zh) * | 2017-03-02 | 2018-09-07 | 中国科学院上海药物研究所 | 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用 |
| CN109748903B (zh) * | 2017-11-01 | 2021-08-10 | 北京协和制药二厂 | 吡法齐明的制备方法 |
| EP3594206A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| EP3594205A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-aryl derivatives for treating a rna virus infection |
| JP2020127293A (ja) * | 2019-02-05 | 2020-08-20 | ファナック株式会社 | ロータコアの製造装置及びロータコアの製造方法、並びにロータ構造 |
| CN110041223B (zh) * | 2019-06-03 | 2021-10-22 | 西北师范大学 | 以肼类化合物为原料氧化合成偶氮类化合物的方法 |
| CN114276273B (zh) * | 2021-12-29 | 2024-06-21 | 维思普新材料（苏州）有限公司 | 一种基于四苯基肼类衍生物的有机电致发光材料及其电子器件 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4292429A (en) * | 1978-03-08 | 1981-09-29 | Ciba-Geigy Corporation | Imidazole urea and amido compounds |
| EE200100492A (et) * | 1999-03-19 | 2002-12-16 | Vertex Pharmaceuticals Incorporated | Ensüümi IMPDH inhibiitorid |
| JP4550811B2 (ja) * | 2003-06-09 | 2010-09-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | パピローマウイルスのインヒビター |
-
2006
- 2006-05-19 FR FR0604496A patent/FR2901273B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-18 JP JP2009511485A patent/JP5399237B2/ja not_active Expired - Fee Related
- 2007-05-18 AR ARP070102162A patent/AR061027A1/es not_active Application Discontinuation
- 2007-05-18 ES ES07729287.8T patent/ES2436772T3/es active Active
- 2007-05-18 WO PCT/EP2007/054843 patent/WO2007135106A1/fr not_active Ceased
- 2007-05-18 PT PT77292878T patent/PT2024350E/pt unknown
- 2007-05-18 BR BRPI0711208-4A patent/BRPI0711208A2/pt not_active IP Right Cessation
- 2007-05-18 EP EP07729287.8A patent/EP2024350B1/fr not_active Not-in-force
- 2007-05-18 MX MX2008014771A patent/MX2008014771A/es active IP Right Grant
- 2007-05-18 US US12/300,998 patent/US8207373B2/en not_active Expired - Fee Related
- 2007-05-18 CN CN2007800218616A patent/CN101466693B/zh not_active Expired - Fee Related
- 2007-05-18 CA CA2652469A patent/CA2652469C/fr not_active Expired - Fee Related
- 2007-05-18 DK DK07729287.8T patent/DK2024350T3/da active
-
2012
- 2012-05-08 US US13/466,530 patent/US9452991B2/en active Active
-
2016
- 2016-09-26 US US15/276,208 patent/US9974779B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537595A5 (enExample) | ||
| JP5399237B2 (ja) | ヒトパピローマウイルス阻害剤としてのピペリジン誘導体 | |
| ES2440267T3 (es) | Compuestos de heterociclo-arilo para la inflamación y usos inmunorrelacionados | |
| TW200530195A (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
| RU2261860C2 (ru) | ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 8А ПРОИЗВОДНЫЕ 8,8А-ДИГИДРОИНДЕНО [1,2-d] ТИАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, НАПРИМЕР В КАЧЕСТВЕ АНОРЕКСИЧЕСКИХ СРЕДСТВ | |
| CA2469228A1 (en) | Azole compound and medicinal use thereof | |
| RU2263113C2 (ru) | Производные 8,8а-дигидроиндено [1,2-d]тиазола, содержащие в положении 2 заместитель с сульфонамидной или сульфоновой структурой, способ их получения и их применение в качестве лекарственного средства | |
| US7868046B2 (en) | (2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing them | |
| BRPI0616217A2 (pt) | tiazolinonas e oxazolinonas e seus usos como inibidores da ptp1b | |
| JP2012012376A (ja) | 新規アシルグアニジン誘導体 | |
| AR052439A1 (es) | Medicamentos para el tratamiento o la prevencion de enfermedades fibroticas | |
| JP4239463B2 (ja) | ３−トリフルオロメチルアニリド誘導体 | |
| ES3018891T3 (en) | Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient | |
| JP5547082B2 (ja) | 新規なヒトパピローマウイルス阻害剤およびそれを含有する医薬組成物 | |
| JP2009534310A5 (enExample) | ||
| JP2003231679A (ja) | アゾール化合物及びその医薬用途 | |
| JP5492764B2 (ja) | 置換スルホンアミド、その製造方法、それを含有する製薬組成物及びその使用 | |
| RU2263669C2 (ru) | Замещенные 8,8a-дигидро-3ah-индено [1,2-d] тиазолы, способ их получения и их применение в качестве лекарственных средств | |
| WO2006082822A1 (ja) | アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤 | |
| HK1216253B (en) | Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient |